Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1;10(6):300.
doi: 10.3390/toxics10060300.

Complexation of 5-Fluorouracil with β-Cyclodextrin and Sodium Dodecyl Sulfate: A Useful Tool for Encapsulating and Removing This Polluting Drug

Affiliations

Complexation of 5-Fluorouracil with β-Cyclodextrin and Sodium Dodecyl Sulfate: A Useful Tool for Encapsulating and Removing This Polluting Drug

Ana M T D P V Cabral et al. Toxics. .

Abstract

The formation of complexes of the drug 5-fluorouracil (5-FU) with β-cyclodextrin (β-CD) and sodium dodecyl sulphate (SDS) was studied through experimental measurements of the ternary mutual diffusion coefficients (D11, D22, D12, and D21) for the systems {5-FU (component 1) + β-CD (component 2) + water} and {5-FU (component 1) + SDS (component 2) + water} at 298.15 K and at concentrations up to 0.05 mol dm-3 by using the Taylor dispersion method, with the objective of removing this polluting drug from the residual systems in which it was present. The results found showed that a coupled diffusion of 5-FU occurred with both β-CD and SDS, as indicated by the nonzero values of the cross-diffusion coefficients, D12 and D21, as a consequence of the complex formation between 5-FU and the β-CD or SDS species. That is, 5-FU was solubilized (encapsulated) by both carriers, although to a greater extent with SDS (K = 20.0 (±0.5) mol-1 dm3) than with β-CD (K = 10.0 (±0.5) mol-1 dm3). Values of 0.107 and 0.190 were determined for the maximum fraction of 5-FU solubilized with β-CD and SDS (at concentrations above its CMC), respectively. This meant that SDS was more efficient at encapsulating and thus removing the 5-FU drug.

Keywords: 5-fluorouracil; complexation; diffusion coefficients; sodium dodecyl sulphate; β-cyclodextrin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Malet-Martino M., Martino R. Clinical Studies of Three Oral Prodrugs of 5-Fluorouracil (Capecitabine, UFT, S-1): A Review. Oncologist. 2002;7:288–323. doi: 10.1634/theoncologist.7-4-288. - DOI - PubMed
    1. Lam P.-L., Lee K.K.-H., Wong R.S.-M., Cheng G.Y.M., Cheng S.Y., Yuen M.C.-W., Lam K.-H., Gambari R., Kok S.H.-L., Chui C.-H. Development of hydrocortisone succinic acid/and 5-fluorouracil/chitosan microcapsules for oral and topical drug deliveries. Bioorg. Med. Chem. Lett. 2012;22:3213–3218. doi: 10.1016/j.bmcl.2012.03.031. - DOI - PubMed
    1. Brunton L.L., Randa Hilal-Dandan R., Knollman B.C., editors. Goodman and Gilman’s: The Pharmacological Basis of Therapeutics. 13th ed. McGraw Hill; New York, NY, USA: 2017.
    1. Heidelberger C., Chaudhuri N.K., Danneberg P., Mooren D., Griesbach L., Duschinsky R., Schnitzer R.J., Pleven E., Scheiner J. Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds. Nature. 1957;179:663–666. doi: 10.1038/179663a0. - DOI - PubMed
    1. Yan S., Zhu J., Wang Z., Yin J., Zheng Y., Chen X. Layer-by-layer assembly of poly(l-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil. Eur. J. Pharm. Biopharm. 2011;78:336–345. doi: 10.1016/j.ejpb.2010.12.031. - DOI - PubMed

LinkOut - more resources